Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484

Parkinson's disease

Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

Elias, J. E., & Gygi, S. P. (2007) · Nature Methods · doi:10.1038/nmeth1019 · Cited by 3,925

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854

The mechanism of action of cyclosporin A and FK506

Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease

Kriks, S., Shim, J., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo‐Reid, L., Auyeung, G., Antonacci, C. L., Buch, A., et al. (2011) · Nature · doi:10.1038/nature10648 · Cited by 1,951

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341

Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells

Lee, S., Lumelsky, N. L., Studer, L., Auerbach, J. M., & McKay, R. D. G. (2000) · Nature Biotechnology · doi:10.1038/76536 · Cited by 1,261

Selective neuronal vulnerability in Parkinson disease

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116

Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons

Graves, S. M., Schwarzschild, S. E., Tai, R., Chen, Y., & Surmeier, D. J. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105409 · Cited by 40

From Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and Opportunities

Mächtel, R., Boros, F. A., Dobert, J. P., Arnold, P., & Zunke, F. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167932 · Cited by 37

Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies

Pazzin, D. B., Previato, T. T. R., Gonçalves, J. I. B., Zanirati, G., Xavier, F. A. C., DaCosta, J. C., & Marinowic, D. R. (2024) · Cells · doi:10.3390/cells13090745 · Cited by 36

Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity

Lawana, V., Um, S. Y., Rochet, J., Turesky, R. J., Shannahan, J. H., & Cannon, J. R. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz210 · Cited by 36

Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson’s Disease

He, S., Zhong, S., Liu, G., & Yang, J. (2020) · Neurodegenerative Diseases · doi:10.1159/000511083 · Cited by 36

Tetraphenylethylene‐Featured Fluorescent Supramolecular Nanoparticles for Intracellular Trafficking of Protein Delivery and Neuroprotection

Liu, J., Sheng, J., Shao, L., Zheng, Q., Li, W., Chen, X., Mao, L., & Wang, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202111213 · Cited by 36

The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease

Henderson, M. X., Henrich, M. T., Geibl, F. F., Oertel, W. H., Brundin, P., & Surmeier, D. J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105687 · Cited by 35

Sex Differences in Dopaminergic Vulnerability to Environmental Toxicants — Implications for Parkinson’s Disease

Adamson, A. B., Buck, S. A., Freyberg, Z., & Miranda, B. R. D. (2022) · Current Environmental Health Reports · doi:10.1007/s40572-022-00380-6 · Cited by 38

A single fluorescent probe to examine the dynamics of mitochondria-lysosome interplay and extracellular vesicle role in ferroptosis

Wang, L.-L., Mai, Y.-Z., Zheng, M., Yan, G., & Jin, J. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.01.003 · Cited by 36

5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease

Badillo‐Ramírez, I., Saniger, J. M., & Rivas-Arancibia, S. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104514 · Cited by 36

Fenpropathrin induces degeneration of dopaminergic neurons via disruption of the mitochondrial quality control system

Jiao, Z., Wu, Y., & Qu, S. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00313-y · Cited by 35

REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model

Ryan, B. J., Bengoa‐Vergniory, N., Williamson, M. G., Kirkiz, E., Roberts, R. F., Corda, G., Sloan, M., Saqlain, S., Cherubini, M., Poppinga, J., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1478-20.2021 · Cited by 38

Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases

Dorostgou, Z., Yadegar, N., Dorostgou, Z., Khorvash, F., & Vakili, O. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25094 · Cited by 35

The Proton-Coupled Monocarboxylate Transporter Hermes Is Necessary for Autophagy during Cell Death

Velentzas, P. D., Zhang, L., Das, G., Chang, T.-K., Nelson, C., Kobertz, W. R., & Baehrecke, E. H. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.09.015 · Cited by 31

Metal–Organic Framework Based Nanozyme System for NLRP3 Inflammasome‐Mediated Neuroinflammatory Regulation in Parkinson's Disease

Li, Q., Ding, X., Chang, Z., Fan, X., Pan, J., Yang, Y., Li, X., Jiang, W., & Fan, K. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202303454 · Cited by 34

Dopamine‐conjugated extracellular vesicles induce autophagy in Parkinson's disease

Sul, J. H., Shin, S., Kim, H. K., Han, J., Kim, J., Son, S., Lee, J., Baek, S. H., Cho, Y., Lee, J., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70018 · Cited by 38

Pathogenesis of Parkinson’s Disease

Xiao, B., Zhou, Z., Chao, Y., & Tan, E.-K. (2025) · Neurologic Clinics · doi:10.1016/j.ncl.2024.12.003 · Cited by 36

Lysosomal ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity

Kim, M. J., Jeong, H., & Krainc, D. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac047 · Cited by 34

Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease

Krainc, T., Monje, M. H. G., Kinsinger, M., Bustos, B. I., & Lubbe, S. J. (2022) · Movement Disorders · doi:10.1002/mds.29260 · Cited by 35

Mechanisms of Glucocerebrosidase Dysfunction in Parkinson’s Disease

Chatterjee, D., & Krainc, D. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168023 · Cited by 33

Disturb mitochondrial associated proteostasis: Neurodegeneration and imperfect ageing

Jagtap, Y. A., Kumar, P., Kinger, S., Dubey, A. R., Choudhary, A., Gutti, R. K., Singh, S., Jha, H. C., Poluri, K. M., & Mishra, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1146564 · Cited by 36

PKM2-mediated neuronal hyperglycolysis enhances the risk of Parkinson's disease in diabetic rats

Ya, Z., Wang, Y., Wu, Y., Tao, C., Xu, R., Chen, Y., Qian, L., Xu, T., & Lian, X. (2022) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2022.11.006 · Cited by 33

Sensory neuropathy and nociception in rodent models of Parkinson's disease

Valek, L., Auburger, G. W. J., & Tegeder, I. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039396 · Cited by 33

Imaging gradual neurodegeneration in a basal ganglia model disease

Hanssen, H., Prasuhn, J., Heldmann, M., Diesta, C. C. E., Domingo, A., Göttlich, M., Blood, A. J., Rosales, R. L., Jamora, R. D. G., Münte, T. F., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25566 · Cited by 33

Heterogeneity of dopamine release sites in health and degeneration

Lebowitz, J. J., & Khoshbouei, H. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104633 · Cited by 33

Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis

Serapide, M. F., L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Giachino, C., & Marchetti, B. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00024 · Cited by 32

Influence of Gut Microbiota on Mental Health via Neurotransmitters: A Review

Liu, T., Feenstra, K. A., Heringa, J., & Huang, Z. (2020) · Journal of Artificial Intelligence for Medical Sciences · doi:10.2991/jaims.d.200420.001 · Cited by 37

iPSCs: A Preclinical Drug Research Tool for Neurological Disorders

Bonaventura, G., Iemmolo, R., Attaguile, G. A., Cognata, V. L., Pistone, B. S., Raudino, G., D’Agata, V., Cantarella, G., Barcellona, M. L., & Cavallaro, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094596 · Cited by 35

Role of dopamine neuron activity in Parkinson's disease pathophysiology

Rademacher, K., & Nakamura, K. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114645 · Cited by 35

Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease

Iarkov, A., Mendoza, C., & Echeverrı́a, V. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.665820 · Cited by 36

The Potential Role of Voltage‐Dependent Anion Channel in the Treatment of Parkinson’s Disease

He, Y., Wang, W., Yang, T., Thomas, E. R., Dai, R., & Li, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4665530 · Cited by 31

Immunological Techniques to Assess Protein Thiol Redox State: Opportunities, Challenges and Solutions

Cobley, J. N., & Husi, H. (2020) · Antioxidants · doi:10.3390/antiox9040315 · Cited by 33

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?

Gundersen, V. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.580311 · Cited by 33

Piezoelectric nanogenerators enabled neuromodulation rescued dopaminergic neuron loss in Parkinson’s disease

Chen, Y., Feng, P., Zhong, G., Liu, J., Jiang, B., Harn, Y., Zhao, D. S., Lin, Z., Zhang, Q., & Shen, Q. (2023) · Nano Energy · doi:10.1016/j.nanoen.2023.109187 · Cited by 31

VPS13C regulates phospho-Rab10-mediated lysosomal function in human dopaminergic neurons

Schröder, L. F., Peng, W., Gao, G., Wong, Y. C., Schwake, M., & Krainc, D. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202304042 · Cited by 30

Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease

Tobore, T. O. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24492 · Cited by 32

Crosstalk of organelles in Parkinson’s disease – MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes

Lang, M., Pramstaller, P. P., & Pichler, I. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00555-7 · Cited by 35

Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications

Iannielli, A., Luoni, M., Giannelli, S. G., Ferese, R., Ordazzo, G., Fossati, M., Raimondi, A., Opazo, F., Corti, O., Prehn, J. H. M., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05330-6 · Cited by 32

A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death

Farzam, A., Chohan, K. L., Strmiskova, M., Hewitt, S. J., Park, D. S., Pezacki, J. P., & Özcelik, D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101377 · Cited by 31

Fucoxanthin Prevents Long-Term Administration l-DOPA-Induced Neurotoxicity through the ERK/JNK-c-Jun System in 6-OHDA-Lesioned Mice and PC12 Cells

Liu, J., Lu, Y., Tang, M., Shao, F., Yang, D., Chen, S., Xu, Z., Zhai, L., Chen, J., Li, Q., et al. (2022) · Marine Drugs · doi:10.3390/md20040245 · Cited by 30

Induced pluripotent stem cell‐based modeling of mutant LRRK 2‐associated Parkinson's disease

Weykopf, B., Haupt, S., Jungverdorben, J., Flitsch, L. J., Hebisch, M., Liu, G., Suzuki, K., Belmonte, J. C. I., Peitz, M., Blaess, S., et al. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14345 · Cited by 30

A monolayer hiPSC culture system for autophagy/mitophagy studies in human dopaminergic neurons

Stathakos, P., Jiménez-Moreno, N., Crompton, L., Nistor, P., Badger, J. L., Barbuti, P. A., Kerrigan, T. L., Randall, A. D., Caldwell, M. A., & Lane, J. D. (2020) · Autophagy · doi:10.1080/15548627.2020.1739441 · Cited by 31

Synthesis, Follow-Up, and Characterization of Polydopamine-like Coatings Departing from Micromolar Dopamine- o -Quinone Precursor Concentrations

Jaramillo, A. M., Barrera-Gutiérrez, R., & Cortés, M. T. (2020) · ACS Omega · doi:10.1021/acsomega.0c00676 · Cited by 30

Solid-phase microextraction integrated nanobiosensors for the serial detection of cytoplasmic dopamine in a single living cell

Chang, Y., Chen, Y., Shao, Y., Li, B., Wu, Y., Zhang, W., Zhou, Y., Yu, Z., Lü, L., Wang, X., et al. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112915 · Cited by 30

Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy

Siwecka, N., Saramowicz, K., Galita, G., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082051 · Cited by 33

Dysfunction of synaptic endocytic trafficking in Parkinson’s disease

Ng, X. Y., & Cao, M. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01624 · Cited by 31

Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits

Laguna, A., Peñuelas, N., González-Sepúlveda, M., Nicolau, A., Arthaud, S., Guillard-Sirieix, C., Picón, M. L., Compte, J., Miquel-Rio, L., Xicoy, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53168-7 · Cited by 33

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification

Kouroupi, G., Antoniou, N., Prodromidou, K., Taoufik, E., & Matsas, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197113 · Cited by 30

Intersection between Redox Homeostasis and Autophagy: Valuable Insights into Neurodegeneration

Park, H., Kim, J., Shin, C., & Lee, S. (2021) · Antioxidants · doi:10.3390/antiox10050694 · Cited by 32

Extracellular miRNAs in redox signaling: Health, disease and potential therapies

Ruiz, G. P., Camara, H., Fazolini, N. P. B., & Mori, M. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.004 · Cited by 30

Overexpression of SIRT3 Suppresses Oxidative Stress-induced Neurotoxicity and Mitochondrial Dysfunction in Dopaminergic Neuronal Cells

Lee, S., Jeon, Y., Jo, M., & Kim, H. (2021) · Experimental Neurobiology · doi:10.5607/en21021 · Cited by 29

The interplay between aging‐associated loss of protein homeostasis and extracellular vesicles in neurodegeneration

Guix, F. X. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24526 · Cited by 30

Protective mechanism of Paeonol on central nervous system

Wu, R., Liu, Y., Zhang, F., Dai, S., Xue, X., Peng, C., Li, Y., & Li, Y. (2023) · Phytotherapy Research · doi:10.1002/ptr.8049 · Cited by 27

Neurodegenerative disorders, metabolic icebergs, and mitohormesis

Phillips, M. C. L., & Picard, M. A. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00435-8 · Cited by 31

Interplay of α-Synuclein Oligomers and Endoplasmic Reticulum Stress in Parkinson'S Disease: Insights into Cellular Dysfunctions

Zeng, H., Liu, Y., Liu, X., Li, J., Lu, L., Cheng, X., Wu, X., Zhang, X., Zheng, Z., & Lu, G. (2024) · Inflammation · doi:10.1007/s10753-024-02156-6 · Cited by 31

Sarcopenia in Parkinson's disease: from pathogenesis to interventions

Gui, M., Lv, L., Hu, S., Qin, L., & Wang, C. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156272 · Cited by 34

Copper(II)-disulfiram loaded melanin-dots for cancer theranostics

Shi, H., Suo, Y., Zhang, Z., Liu, R., Liu, H., & Cheng, Z. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102340 · Cited by 28

Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factors

Naoi, M., Maruyama, W., & Shamoto‐Nagai, M. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02427-8 · Cited by 32

Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases

Butterfield, D. A., Favia, M., Spera, I., Campanella, A., Lanza, M., & Castegna, A. (2022) · Molecules · doi:10.3390/molecules27030951 · Cited by 29

Unveiling the Role of DJ‐1 Protein in Vesicular Storage and Release of Catecholamine with Nano/Micro‐Tip Electrodes

Yue, Q., Li, X., Wu, F., Ji, W., Zhang, Y., Yu, P., Zhang, M., Ma, W., Wang, M., & Mao, L. (2020) · Angewandte Chemie · doi:10.1002/ange.202002455 · Cited by 28

A mitochondria-targeted fluorescent probe based on biocompatible RBH-U for the enhanced response of Fe3+ in living cells and quenching of Cu2+ in vitro

Xu, W., Ahmed, F., & Xiong, H. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.340925 · Cited by 28

The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson’s therapeutics

Rubilar, J. C., Outeiro, T. F., & Klein, A. D. (2024) · Brain · doi:10.1093/brain/awae070 · Cited by 29

Parkinson’s disease and translational research

Dinter, E., Saridaki, T., Diederichs, L., Reichmann, H., & Falkenburger, B. H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00223-0 · Cited by 30

A bifunctional probe that allows dual-channel fluorescence turn-on detection of protein aggregates and hydrogen peroxide in neurodegenerative diseases

Ma, J., Wang, X., Li, N., & Cheng, Y. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130536 · Cited by 25

Subcellular delivery of lipid nanoparticles to endoplasmic reticulum and mitochondria

Shi, Y., Luo, Z., & You, J. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1803 · Cited by 30

Advances in the Functions of Thioredoxin System in Central Nervous System Diseases

Jia, J., Xu, G., Zhu, D., Liu, H., Zeng, X., & Li, L. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0079 · Cited by 28

The reactivity of copper complexes with neuronal peptides promoted by catecholamines and its impact on neurodegeneration

Bacchella, C., Dell’Acqua, S., Nicolis, S., Monzani, E., & Casella, L. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214756 · Cited by 27

Bioinspired metal-organic framework nanozyme reinforced with thermosensitive hydrogel for regulating inflammatory responses in Parkinson’s disease

Fan, X., Zhang, T., Ding, X., Gu, Y., Li, Q., Jiang, W., & Fan, K. (2023) · Nano Research · doi:10.1007/s12274-023-6304-8 · Cited by 27

The AAV-α-Synuclein Model of Parkinson’s Disease: An Update

Björklund, A., & Mattsson, B. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240207 · Cited by 31

Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase

Zheng, J., Jeon, S., Jiang, W., Burbulla, L. F., Ysselstein, D., Oevel, K., Krainc, D., & Silverman, R. B. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01294 · Cited by 27

Autophagy and Redox Homeostasis in Parkinson’s: A Crucial Balancing Act

Jiménez-Moreno, N., & Lane, J. D. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8865611 · Cited by 26

Calcium Channel blockers are associated with reduced risk of Parkinson's disease in patients with hypertension: A population-based retrospective cohort study

Tseng, Y.-F., Lin, H., Chao, J. C.-J., Hsu, C., & Lin, H. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117412 · Cited by 26

Selective Advantages of Synapses in Evolution

Moroz, L. L., & Romanova, D. Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.726563 · Cited by 27

Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects

Huang, Y., Zhu, M., Liu, Z., Hu, R., Li, F., Song, Y., Geng, Y., Ma, W., Song, K., & Zhang, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997808 · Cited by 27

Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes

Franco, R., Sánchez-Arias, J. A., Navarro, G., & Lanciego, J. L. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00052 · Cited by 28

G6PD deficiency triggers dopamine loss and the initiation of Parkinson’s disease pathogenesis

Stykel, M. G., Siripala, S. V., Soubeyrand, E., Coackley, C. L., Lu, P., Camargo, S., Thevasenan, S., Figueroa, G. B., So, R. W. L., Stuart, E., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115178 · Cited by 25

Loss of intracellular ATP affects axoplasmic viscosity and pathological protein aggregation in mammalian neurons

Guillaud, L., Garanzini, A., Zakhia, S., de la Fuente, S., Dimitrov, D., Boerner, S., & Terenzio, M. (2025) · Science Advances · doi:10.1126/sciadv.adq6077 · Cited by 27

Ferroptosis in central nervous system injuries: molecular mechanisms, diagnostic approaches, and therapeutic strategies

Huang, Q., Zhang, H., Chen, S., Wang, Y., & Zhou, J. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1593963 · Cited by 28

Fluorescent Probes Design Strategies for Imaging Mitochondria and Lysosomes

Chen, H., Yu, Z., Ren, S., & Qiu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.915609 · Cited by 25

Role of Protein Damage Inflicted by Dopamine Metabolites in Parkinson’s Disease: Evidence, Tools, and Outlook

Hurben, A. K., & Tretyakova, N. Y. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00193 · Cited by 25

Melatonin Mitigates Rotenone-Induced Oxidative Stress and Mitochondrial Dysfunction in the Drosophila melanogaster Model of Parkinson’s Disease-like Symptoms

Rasheed, M. Z., Khatoon, R., Talat, F., Alam, M. M., Tabassum, H., & Parvez, S. (2023) · ACS Omega · doi:10.1021/acsomega.2c03992 · Cited by 25

Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease

Shehadeh, J., Double, K. L., Murphy, K. E., Bobrovskaya, L., Reyes, S., Dunkley, P. R., Halliday, G. M., & Dickson, P. W. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104524 · Cited by 25

Lipid accumulation drives cellular senescence in dopaminergic neurons

Russo, T., & Rießland, M. (2024) · Aging · doi:10.18632/aging.206030 · Cited by 25

Intercellular Adhesion Molecule 1 (ICAM-1): An Inflammatory Regulator with Potential Implications in Ferroptosis and Parkinson’s Disease

Miller, M. R., Landis, H. E., Miller, R. E., & Tizabi, Y. (2024) · Cells · doi:10.3390/cells13181554 · Cited by 26

Coordination-based molecular nanomaterials for biomedically relevant applications

Wang, C.-F., Wang, W., Tan, J.-Y., Zhang, X., Yuan, D.-Q., & Zhou, H.-C. (2021) · Coordination chemistry reviews · doi:10.1016/j.ccr.2020.213752 · Cited by 22

High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells

Sarrafha, L., Parfitt, G. M., Reyes, R., Goldman, C., Coccia, E., Kareva, T., & Ahfeldt, T. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100463 · Cited by 25

Targeting of Lysosomal Pathway Genes for Parkinson's Disease Modification: Insights From Cellular and Animal Models

Abe, T., & Kuwahara, T. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.681369 · Cited by 24

METTL14 Regulates the m6A Modification of TRAF6 to Suppress Mitochondrial Dysfunction and Ferroptosis in Dopaminergic Neurons via the cGAS-STING Pathway

Shao, L., Hu, F., Xu, R., Nie, H., Zhang, H., & Ping, Z. (2023) · Current Molecular Medicine · doi:10.2174/0115665240263859231018110107 · Cited by 24

β2-subunit alternative splicing stabilizes Cav2.3 Ca2+ channel activity during continuous midbrain dopamine neuron-like activity

Siller, A., Hofer, N. T., Tomagra, G., Burkert, N., Heß, S., Benkert, J., Gaifullina, A., Spaich, D., Duda, J., Pötschke, C., et al. (2022) · eLife · doi:10.7554/elife.67464 · Cited by 23

DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease

Cai, W., Wakamatsu, K., Zucca, F. A., Wang, Q., Yang, K., Honarvar, N. M., Srivastava, P., Tanaka, H., Holly, G., Casella, L., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102414 · Cited by 24

Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria

Klein, A. D., & Outeiro, T. F. (2023) · Nature Communications · doi:10.1038/s41467-023-42107-7 · Cited by 23

IR-MALDESI mass spectrometry imaging of underivatized neurotransmitters in brain tissue of rats exposed to tetrabromobisphenol A

Bagley, M. C., Ekelöf, M., Rock, K. D., Patisaul, H. B., & Muddiman, D. C. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1420-0 · Cited by 23

The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson’s disease and in schizophrenia

Ben‐Shachar, D. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02120-x · Cited by 23

The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease

Burbulla, L. F., & Krainc, D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104545 · Cited by 23

Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease

Dassati, S., Schweigreiter, R., Buechner, S., & Waldner, A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108378 · Cited by 22

Neuronal mitochondrial morphology is significantly affected by both fixative and oxygen level during perfusion

Kim, S. Y., Strucinska, K., Osei, B., Han, K., Kwon, S., & Lewis, T. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1042616 · Cited by 21

Cyclophilin D in Mitochondrial Dysfunction: A Key Player in Neurodegeneration?

Coluccino, G., Muraca, V. P., Corazza, A., & Lippe, G. (2023) · Biomolecules · doi:10.3390/biom13081265 · Cited by 23

Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease

Blagov, A. V., Postnov, A. Y., Sukhorukov, V. N., Popov, M. A., Uzokov, J., & Orekhov, A. N. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2901036 · Cited by 26

Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease

Mei, M., Zhou, Y., Liu, M., Zhao, F., Wang, C., Ding, J., Lu, M., & Hu, G. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107758 · Cited by 22

The interplay between electron transport chain function and iron regulatory factors influences melanin formation in Cryptococcus neoformans

Xue, P., Sánchez‐León, E., Hu, G., Lee, C. W. J., Black, B., Brisland, A., Li, H., Jung, W. H., & Kronstad, J. W. (2024) · mSphere · doi:10.1128/msphere.00250-24 · Cited by 21

Dopamine oxidation mediates a human-specific cascade of mitochondrial and lysosomal dysfunction in Parkinson's disease.

Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., Jeon, S., Santos, D. P., Blanz, J., Obermaier, C. D., Strojny, C., et al. (2017) · Science · Cited by 3

The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease

Hastings, T. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9257-z · Cited by 199

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease

Minakaki, G., Krainc, D., & Burbulla, L. F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.580634 · Cited by 87

Dopamine Oxidation and Parkinson’s Disease

Barrett, C. W., Bucher, M. L., & Hastings, T. G. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00116 · Cited by 1

Toxic effects of the oxidized products of the neurotransmitter dopamine on mitochondria and their implications in Parkinson's disease

Arduini, I. (2008) · Padua Research Archive (University of Padova)